Interferon-γ down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine

Pancreas

Volumn 38, Issue 2, 2009, Pages 224-226

  Mori Iwamoto, Sayaka ^a   Taba, Kumiko ^a   Kuramitsu, Yasuhiro ^b   Ryozawa, Shomei ^a   Tanaka, Toshiyuki ^a   Maehara, Shin Ichiro ^c   Maehara, Yoshihiro ^c   Okita, Kiwamu ^d   Nakamura, Kazuyuki ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

^d Shimonoseki Kousei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GEMCITABINE; HEAT SHOCK PROTEIN 27; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; HSPB1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL ASSAY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; HUMAN; KNOCKOUT GENE; LETTER; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; WESTERN BLOTTING; DRUG ANTAGONISM; GENETICS; METABOLISM; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; DEOXYCYTIDINE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INTERFERON-GAMMA; PANCREATIC NEOPLASMS;

EID: 65349170081     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181773970     Document Type: Letter

References (8)

1. Williamson RC. Pancreatic cancer: the greatest oncological challenge. Br Med J. 1988;296:445-446.
2. Gordis L, Gold EB. Epidemiology of pancreatic cancer. World J Surg. 1984;8:808-821.
3. Carmichael J, Fink U, Russell RC, et al. Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer. 1996;73:101-105.
4. Shi X, Liu S, Kleeff J, Friess H, et al. Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology. 2002;62:354-362.
5. Maehara S, Tanaka S, Shimada M, et al. Selenoprotein P, as a predictor for evaluating gemcitabine resistance in human pancreatic cancer cells. Int J Cancer. 2004;112: 184-189.
6. Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, et al. Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. Int J Oncol. 2007;31:1345-1350.
7. Arrigo AP. Hsp27: novel regulator of intracellular redox state. IUBMB Life. 2001;52:303-307.
8. Concannon CG, Gorman AM, Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis. 2003;8:61-70.